These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4370664)

  • 1. Comparative immunogenicity of irradiated, neuraminidase treated, and fused cells of a strain-restricted sarcoma.
    Liao SK; Carr DH
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 82(2):133-42. PubMed ID: 4370664
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
    Currie GA; Bagshawe KD
    Br J Cancer; 1969 Mar; 23(1):141-9. PubMed ID: 5768430
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of active immune state by multinucleate tumour cells in mice.
    Liao SK; Carr DH
    Experientia; 1973 May; 29(5):597-9. PubMed ID: 4354198
    [No Abstract]   [Full Text] [Related]  

  • 4. Splenic cellular responses in vitro after tumour-immunization.
    Liao SK; Carr DH
    Experientia; 1973 May; 29(5):604-5. PubMed ID: 4354199
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.
    Simmons RL; Rios A; Ray PK
    J Surg Oncol; 1972; 4(4):298-305. PubMed ID: 5083567
    [No Abstract]   [Full Text] [Related]  

  • 7. Sarcoma induction in mice by methylcholanthrene. Antigenicity tests of sarcomas induced in thymus grafted and control animals.
    Marchant J
    Br J Cancer; 1969 Jun; 23(2):383-90. PubMed ID: 5788047
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serological determination of specific surface antigens of cells from sarcomas induced by methylcholanthrene].
    Lezhneva OM
    Tsitologiia; 1970 May; 12(5):666-74. PubMed ID: 4915907
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 11. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
    Klein G; Klein E
    Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies against cells of methylcholanthrene sarcoma in the blood of intact mice].
    Fedorovskaia MI; Vetrova EP; Umanskii IuA
    Biull Eksp Biol Med; 1973 Jul; 76(7):78-80. PubMed ID: 4774443
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumour immunity--1. Differential response of neuraminidase-treated and x-irradiated tumour vaccine.
    Ray PK; Thakur VS; Sundaram K
    Eur J Cancer (1965); 1975 Jan; 11(1):1-8. PubMed ID: 1132396
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME
    J Natl Cancer Inst; 1974 Dec; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of subpopulations of immune lymphocytes against murine sarcoma cells.
    Lamon EW; Wigzell H
    Transplantation; 1974 Oct; 18(4):368-71. PubMed ID: 4547517
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors.
    Borberg H; Oettgen HF; Choudry K; Beattie EJ
    Int J Cancer; 1972 Nov; 10(3):539-47. PubMed ID: 4668494
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor immune response following injection of neuraminidase-treated sarcoma cells.
    Faraci RP; Marrone JA; Ketcham AS
    Ann Surg; 1975 Mar; 181(3):359-62. PubMed ID: 1130852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
    Stjernswärd J
    J Natl Cancer Inst; 1968 Jan; 40(1):13-22. PubMed ID: 5635014
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of immunization with an allogeneic tumor on the growth of primary methylcholanthrene-induced sarcomas in rats.
    Usubuchi I; Kudo H; Kano M; Suga M
    Tohoku J Exp Med; 1976 May; 119(1):79-83. PubMed ID: 951705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.